Atossa Therapeutics, Inc.
- ATOS
- NASDAQ
- Biotechnology
- Breast Cancer Therapeutics
- Women's Oncology
$2.91
Today +9.81%Quote Oct 16, 2026, 08:00 PM UTC
+21.25%over the last month
Max drawdown −20.8%From 1-month high 0.0%3 months +16.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$29.0M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$42.50
+1360.5% from here
Floor
$2.75
5.6% below price
Where the price sits
5 analysts
Analyst range, low to high
$10.00$75.00
- Price $2.91
- Resistance $3.05
- Consensus $42.50
Analysts' average target sits about 1360% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ATOSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
16